Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
3
×
clinical trials
life sciences
national blog main
raleigh-durham blog main
raleigh-durham top stories
biotech
boston blog main
drugs
eli lilly
fda
indiana blog main
indiana top stories
lasmiditan
migraine research foundation
national
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
teva pharmaceutical
texas blog main
texas top stories
triptans
wisconsin blog main
wisconsin top stories
acadia pharmaceuticals
adverum biotechnologies
aimmune
alder biopharmaceutical
alk
allergan
alprazolam
american academy of neurology
atogepant
What
decades
3
×
drug
approval
fda
migraine
new
won
acute
addresses
advanced
arguments
arrival
award
big
bio
cancer
causes
class
commercialized
companies
competitors
condition
data
death
dems
drugs
eli
friday
giant
given
giving
immunotherapy
lasmiditan
lilly
lilly’s
longer
lung
make
medical
medication
Language
unset
Current search:
amgen
×
decades
×
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
